Plasma Orexin-A Levels and Body Composition in COPD

Slides:



Advertisements
Similar presentations
Kanazawa Hiroshi , MD, Hirata Kazuto , MD, Yoshikawa Junichi , MD 
Advertisements

Han-Pin Kuo, M.D., Ph.D., Chieh-Teng Yu, M.D.  CHEST 
Tell-tale Telangiectasias
Colloquium on Therapy of Right Heart Failure
Environmental Causes of Cancer of the Lung Other Than Tobacco Smoke
Effects of One-Legged Exercise Training of Patients With COPD
When to Be Rash About a Fever and Headache
Right-Sided Chest Pain with Progressive Dyspnea
Volume 56, Issue 1, Pages (July 1969)
Volume 102, Issue 3, Pages (September 1992)
Volume 119, Issue 4, Pages (April 2001)
Epidemiology and Treatment of Lung Cancer in Seattle
Effects of Medroxyprogesterone Acetate in Obstructive Sleep Apnea
Bovine Tuberculosis Eradication
Volume 136, Issue 6, Pages (December 2009)
Robert Pickering, M.D, Fernando J. Martinez, M.D  CHEST 
Hyperbaric Oxygenation in Cardiac and Pulmonary Disease
Treatment of Sarcoidosis With Infliximab
Volume 121, Issue 4, Pages (April 2002)
Volume 125, Issue 4, Pages (April 2004)
Air Pollution and Chest Disease
Effect of Vitamin E on Exhaled Ethane in Cigarette Smokers
Navin K. Jain, MD, Thiam H. Lie, MD, FCCP  CHEST 
Bruce K. Rubin, MEngr, MD, FCCP, Markus O. Henke, MD  CHEST 
Clinical and Personality Profiles and Survival in Patients With COPD
Volume 45, Issue 6, Pages (June 1964)
Fever, Skin Eruption, Low Serum Gammaglobulin in a Child with Leukemia
Effects of Prostaglandin E1 on Oxygen Delivery and Consumption in Patients with the Adult Respiratory Distress Syndrome  Henry J. Silverman, M.D., F.C.C.P. 
Volume 106, Issue 3, Pages (September 1994)
Volume 112, Issue 2, Pages (August 1997)
Advance Directive Education During Pulmonary Rehabilitation
Volume 107, Issue 5, Pages (May 1995)
Volume 113, Issue 4, Pages (April 1998)
The Therapeutic Potential of Hyaluronan in COPD
Volume 124, Issue 6, Pages (December 2003)
Zaid J. Yaqoob, MD, Sadeer G. Al-Kindi, MD, Joe G. Zein, MD  CHEST 
Breakage of Forceps Valve Cover and Its Introduction into a Patient
Observers in the Medical Setting
Maximal Midexpiratory Flow as an Index of Acute Airway Changes
Handedness and Sleep Apnea
Lung Changes in Ankylosing Spondylitis
Apnea in the Nonobese CHEST Volume 153, Issue 4, (April 2018)
Counterpoint: Should All ICU Patients Receive Continuous Sedation? No
Volume 143, Issue 1, Pages (January 2013)
Imaging for the Management of Community-Acquired Pneumonia
Risk of Aspiration Pneumonia in the Elderly
Possible Role of Statins in COPD-Related Pulmonary Hypertension
Evolution in Reimbursement for Sleep Studies and Sleep Centers
Acute Pulmonary Injury in Association With Amiodarone
Bedside Calibration Of Pulmonary Artery Catheters
Invasive Pulmonary Aspergillosis
Pulmonary Manifestations in a Case of Multiple Myeloma
Effects of Beta-Adrenergic Agents on Hypokalemia
Myocardial Sarcoidosis Unresponsive to Steroids
Ribavirin in Desquamative Interstitial Pneumonia
Volume 42, Issue 2, Pages (August 1962)
Calcification of the Coronary Artery
Takeshi Wajima, M.D., Ph.D., Olin E. Teague  CHEST 
John M. Yackee, M.D., Reed M. Shnider, M.D., Alan G. Wasserman, M.D. 
Volume 72, Issue 5, Pages (November 1977)
Infective Exacerbations of COPD
Volume 143, Issue 6, Pages (June 2013)
Adrenergic Bronchodilators and Potassium
Volume 133, Issue 4, Pages (April 2008)
Systemic Inflammation, COPD, and Pulmonary Hypertension
Volume 108, Issue 5, Pages (November 1995)
Hyperventilation Syndrome
New Members of the Editorial Board
John Reid, MD, Donald Cockcroft, MD  CHEST 
Does the Type of Surgical Operation Influence the Changes Observed in Fibrinolytic Activity After Cardiopulmonary Bypass?  J.M. Raya Sanchez, MD, J.M.
Presentation transcript:

Plasma Orexin-A Levels and Body Composition in COPD Matsumura Takeshi , MD, Nakayama Mika , MD, Satoh Hiroaki , MD, Naito Asuka , MD, Kamahara Kazuyuki , MD, Sekizawa Kiyohisa , MD  CHEST  Volume 123, Issue 4, Pages 1060-1065 (April 2003) DOI: 10.1378/chest.123.4.1060 Copyright © 2003 The American College of Chest Physicians Terms and Conditions

Figure 1 BMI (top left, A), FM (top right, B), FFM (bottom left, C), and plasma orexin-A (bottom right, D) levels in control subjects (open columns), NW group patients (hatched columns), and UW group patients (closed columns). Results are reported as mean ± SE. Significant differences between two columns are indicated by *p < 0.05 and **p < 0.01. CHEST 2003 123, 1060-1065DOI: (10.1378/chest.123.4.1060) Copyright © 2003 The American College of Chest Physicians Terms and Conditions

Figure 2 Relationship between BMI and plasma orexin-A levels (top, A), FM and plasma orexin-A levels (center, B), and FFM and plasma orexin-A levels (bottom, C) in patients with COPD. In patients with COPD, plasma orexin-A levels significantly correlated with BMI (r = 0.49, p = 0.03) [top, A] and FM (r = 0.53, p = 0.03) [center, B] values, whereas a significant relationship was not observed between FFM values and plasma orexin-A levels (r = 0.22, p = 0.35) [bottom, C]. CHEST 2003 123, 1060-1065DOI: (10.1378/chest.123.4.1060) Copyright © 2003 The American College of Chest Physicians Terms and Conditions

Figure 3 Relationship between BMI and FEV1 percentage of predicted (% pred) (top left, A), FM and FEV1 percentage of predicted (top right, B), FFM and FEV1 percentage of predicted (bottom left, C), and plasma orexin-A levels and FEV1 percentage of predicted (bottom right, D) in patients with COPD. Neither BMI (r = 0.39, p = 0.09) [top left, A], FM (r = 0.38, p = 0.10) [top right, B], FFM (r = 0.16, p = 0.48) [bottom left, C], nor plasma orexin-A levels (r = 0.07, p = 0.77) [bottom right, D] were significantly correlated with FEV1 percentage of predicted in patients with COPD. CHEST 2003 123, 1060-1065DOI: (10.1378/chest.123.4.1060) Copyright © 2003 The American College of Chest Physicians Terms and Conditions